Descripción

Overview of platelet-rich plasma (PRP) therapy for non-scarring alopecia, illustrating the preparation process and growth factor-mediated mechanisms of action.

Figure 3

Diagram

Source Paper

Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.

Pharmaceutics (2022)

PMID: 35335987

DOI: 10.3390/pharmaceutics14030612

Cite This Figure

![Figure 3: Overview of platelet-rich plasma (PRP) therapy for non-scarring alopecia, illustrating the preparation process and growth factor-mediated mechanisms of action.]()

> Source: Talagavadi Channaiah Anudeep et al. "Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.." *Pharmaceutics*, 2022. PMID: [35335987](https://pubmed.ncbi.nlm.nih.gov/35335987/)

<figure>
  <img src="" alt="Overview of platelet-rich plasma (PRP) therapy for non-scarring alopecia, illustrating the preparation process and growth factor-mediated mechanisms of action." />
  <figcaption>Figure 3. Overview of platelet-rich plasma (PRP) therapy for non-scarring alopecia, illustrating the preparation process and growth factor-mediated mechanisms of action.<br>  Source: Talagavadi Channaiah Anudeep et al. "Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.." <em>Pharmaceutics</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35335987/">35335987</a></figcaption>
</figure>

Evidencia relacionada

Minoxidil para Alopecia Androgenética

Calificación A · 299 estudios

Finasteride para Alopecia Androgenética

Calificación A · 206 estudios

Terapia PRP para Alopecia Areata

Calificación A · 89 estudios

Minoxidil para Alopecia Areata

Calificación A · 122 estudios

Terapia PRP para Alopecia Androgenética

Calificación A · 144 estudios